Related Experiment Videos

Mediterranean diet in secondary prevention of CHD

Michel de Lorgeril1, Patricia Salen

  • 1Laboratoire Cœur and Nutrition, TIMC-IMAG, CNRS UMR 5525, Faculté de Médecine de Grenoble, Université de Grenoble, 38706 La Tronche, France. michel.delorgeril@ujf-grenoble.fr

Public Health Nutrition
|December 15, 2011
PubMed

Insights

The Mediterranean diet is recommended for secondary prevention of coronary heart disease (CHD). This dietary pattern effectively reduces cardiac events and improves survival in patients with existing heart conditions.

Area of Science:

  • Cardiovascular Medicine
  • Nutritional Science
  • Preventive Cardiology

Background:

  • Coronary heart disease (CHD) poses significant mortality risks, primarily from sudden cardiac death (SCD) and chronic heart failure (CHF).
  • Recurrent cardiac events are driven by coronary thrombosis, linked to atherosclerotic plaque instability and lipid content.
  • Preventive strategies aim to mitigate thrombosis, ventricular arrhythmias, and left ventricular dysfunction.

Purpose of the Study:

  • To review current knowledge on the Mediterranean diet's role in secondary prevention of CHD.
  • To evaluate the Mediterranean diet's efficacy compared to other interventions.

Main Methods:

  • Literature review of studies on adult coronary patients at high risk of cardiac death.
  • Analysis of existing research on dietary patterns and CHD outcomes.

Main Results:

  • The Mediterranean diet is recognized for its effectiveness in secondary CHD prevention.
  • Unlike some pharmacological approaches, the Mediterranean diet demonstrates a significant impact on patient survival.
  • It addresses key pathological mechanisms including coronary atherosclerosis, thrombosis, and risk of fatal complications.

Conclusions:

  • The traditional Mediterranean diet is a proven strategy for reducing coronary atherosclerosis and thrombosis.
  • It effectively lowers the risk of fatal outcomes such as sudden cardiac death and heart failure in CHD patients.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...